Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 186

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study

Open access
Dossus, Laure, Rinaldi, Sabina, Becker, Susen, Lukanova, Annekatrin, Tjonneland, Anne, Olsen, Anja, Stegger, Jakob, Overvad, Kim, Chabbert-Buffet, Nathalie, Jimenez-Corona, Aida, Clavel-Chapelon, Francoise, Rohrmann, Sabine, Teucher, Birgit, Boeing, Heiner, Schütze, Madlen, Trichopoulou, Antonia, Benetou, Vassiliki, Lagiou, Pagona, Palli, Domenico, Berrino, Franco, Panico, Salvatore, Tumino, Rosario, Sacerdote, Carlotta, Redondo, Maria-Luisa, Travier, Noémie, Sanchez, Maria-Jose, Altzibar, Jone M, Chirlaque, Maria-Dolores, Ardanaz, Eva, Bueno-de-Mesquita, H Bas, van Duijnhoven, Fränzel J B, Onland-Moret, N Charlotte, Peeters, Petra H M, Hallmans, Goran, Lundin, Eva, Khaw, Kay-Tee, Wareham, Nicholas, Allen, Naomi, Key, Tim J, Slimani, Nadia, Hainaut, Pierre, Romaguera, Dora, Norat, Teresa, Riboli, Elio, Kaaks, Rudolf · 2010 · Endocrine-Related Cancer

Abstract

Obesity, a major risk factor for endometrial cancer, is a low-grade inflammatory state characterized by elevated concentrations of cytokines and acute phase reactants. The current study had two aims: first to investigate the associations of C-reactive protein (CRP), interleukin 6 (IL6), and IL1 receptor antagonist (IL1Ra) with endometrial cancer risk and second to examine to which extent these markers can influence the association between obesity and endometrial cancer. We conducted a case–control study, nested within the European Prospective Investigation into Cancer and Nutrition, which comprised 305 incident cases of endometrial cancer and 574 matched controls. CRP, IL6, and IL1Ra were measured in prospectively collected blood specimens by immunoassays. Data were analyzed using conditional logistic regression. All statistical tests were two-sided, and P values <0.05 were considered statistically significant. We observed a significant increase in risk of endometrial cancer with elevated levels of CRP (odds ratio (OR) for top versus bottom quartile: 1.58, 95% confidence interval (CI): 1.03–2.41, Ptrend=0.02), IL6 (OR for top versus bottom quartile: 1.66, 95% CI: 1.08–2.54, Ptrend=0.008), and IL1Ra (OR for top versus bottom quartile: 1.82, 95% CI: 1.22–2.73, Ptrend=0.004). After adjustment for body mass index (BMI), the estimates were strongly reduced and became non-significant. The association between BMI and endometrial cancer was also substantially attenuated (∼10–20%) after adjustment for inflammatory markers, even when the effects of C-peptide or estrone had already been taken into account. We provided epidemiological evidence that chronic inflammation might mediate the association between obesity and endometrial cancer and that endometrial carcinogenesis could be promoted by an inflammatory milieu.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1677/erc-10-0053

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 186

Metadata

Authors
Dossus, L., Rinaldi, S., Becker, S., Lukanova, A., Tjonneland, A., Olsen, A., Stegger, J., Overvad, K., Chabbert-Buffet, N., Jimenez-Corona, A., Clavel-Chapelon, F., Rohrmann, S., Teucher, B., Boeing, H., Schütze, M., Trichopoulou, A., Benetou, V., Lagiou, P., Palli, D., Berrino, F., Panico, S., Tumino, R., Sacerdote, C., Redondo, M.-L., Travier, N., Sanchez, M.-J., Altzibar, J. M., Chirlaque, M.-D., Ardanaz, E., Bueno-de-Mesquita, H. B., van Duijnhoven, F. J. B., Onland-Moret, N. C., Peeters, P. H. M., Hallmans, G., Lundin, E., Khaw, K.-T., Wareham, N., Allen, N., Key, T. J., Slimani, N., Hainaut, P., Romaguera, D., Norat, T., Riboli, E., & Kaaks, R.
Venue
Endocrine-Related Cancer
Published
2010-12
Volume
17
Issue
4
Pages
1007-1019
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2147496696
Cited by
186
References
10
FWCI
2.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.